← Open Payments lookup

RAUL ULLOA VALLADARES: Open Payments

NPI 1922574185 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,238 in 100 payments from 12 companies in 2025. Trend: 2023 $1,950 · 2024 $1,580 · 2025 $2,238

Food & beverage: $2,229Education: $9
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.17$347
Alkermes, Inc.15$342
Indivior Inc.11$336
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$226
E.R. Squibb & Sons, L.L.C.10$226
Neurocrine BioSciences, Inc.7$199
Janssen Pharmaceuticals, Inc10$193
ABBVIE INC.6$119
Luye Pharma (USA) Ltd.5$88
Otsuka America Pharmaceutical, Inc.4$87

Products named: SUBLOCADE, UZEDY, CAPLYTA, COBENFY, INGREZZA, INVEGA SUSTENNA, VIVITROL, ARISTADA.

Industry payments across FL — which companies pay providers there.